- Home
- » Tags
- » Libivirumab
Top View
- Assessment of the Evolution of Cancer Treatment Therapies
- Public Broadly Neutralizing Antibodies Against Hepatitis B Virus in Individuals with Elite Serologic Activity
- Tim Malawi Mai Multe
- Who Drug Information
- 14897/06 ADD 1 ME/Mpd 1 DG E II COUNCIL of the EUROPEAN
- Gm, Ke, Lr, Ls, Mw, Mz, Na, Rw, Sd, Sl, St, Sz, Tz, Ug, Zm, Zw
- Antiviral Therapy in Chronic Hepatitis B Viral Infection During Pregnancy
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- (INN) for Biological and Biotechnological Substances
- Redacted Synopsis
- Q:\Users\Brendac\Pharmaceutical Zeroforzero Initiative FINAL Edited
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Supplemental Table 1: Inclusion and Exclusion Criteria
- WO 2016/059622 A2 21 April 2016 (21.04.2016) P O P C T
- INN-Nimet 1 1.7.2019 a Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum Abagovomabi Abaloparatide Abaloparatidum Abalopara